Immunocore Holdings plc (IMCR) stock
IMCRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/3014% below fair value
$27.51−0.30 (-1.08%)
Close on Nov 18, 2026Market cap $1.42BP/E –Yield 0.00%
Immunocore market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Immunocore's market cap was $1.63B on Nov 11, 2026, against $1.99B a year earlier. Over the last 5 years it ranged from $6.02M to $3.48B, with a median of $1.64B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.63B | -7.0% |
| 2025 | Dec 31, 2025 | $1.75B | +18.7% |
| 2024 | Dec 31, 2024 | $1.48B | -55.1% |
| 2023 | Dec 29, 2023 | $3.29B | +27024.2% |
| 2022 | Dec 30, 2022 | $12.11M | – |
See a number that looks wrong?